Citigroup Maintains Buy on Eli Lilly, Raises Price Target to $1600

Benzinga Newsdesk www.benzinga.com Positive 76.4%

Neg 0% Neu 0% Pos 76.4%

Citigroup analyst Geoff Meacham maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1500 to $1600.